ExodusPoint Capital Management’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-104,602
| Closed | -$1.61M | – | 1680 |
|
|
2025
Q4 | $1.61M | Sell |
104,602
-110,990
| -51% | -$1.22M | 0.01% | 833 |
|
|
2025
Q3 | $2.14M | Buy |
215,592
+116,461
| +117% | +$1.21M | 0.02% | 713 |
|
|
2025
Q2 | $983K | Sell |
99,131
-11,039
| -10% | -$116K | 0.01% | 968 |
|
|
2025
Q1 | $1.43M | Buy |
+110,170
| New | +$1.46M | 0.01% | 819 |
|
|
2023
Q4 | – | Sell |
-81,806
| Closed | -$1.21M | – | 1597 |
|
|
2023
Q3 | $1.21M | Buy |
81,806
+10,232
| +14% | +$144K | 0.01% | 892 |
|
|
2023
Q2 | $925K | Sell |
71,574
-31,869
| -31% | -$363K | 0.01% | 1132 |
|
|
2023
Q1 | $1.01M | Buy |
103,443
+91,343
| +755% | +$975K | 0.01% | 1134 |
|
|
2022
Q4 | $129K | Buy |
+12,100
| New | +$141K | ﹤0.01% | 1504 |
|
|
2022
Q2 | – | Sell |
-153,758
| Closed | -$1.67M | – | 2050 |
|
|
2022
Q1 | $1.67M | Buy |
+153,758
| New | +$1.87M | 0.02% | 874 |
|
|
2021
Q3 | – | Sell |
-27,045
| Closed | -$266K | – | 2235 |
|
|
2021
Q2 | $266K | Sell |
27,045
-48,694
| -64% | -$443K | ﹤0.01% | 1811 |
|
|
2021
Q1 | $745K | Buy |
+75,739
| New | +$624K | 0.01% | 1101 |
|
|
2020
Q4 | – | Sell |
-50,048
| Closed | -$216K | – | 2047 |
|
|
2020
Q3 | $216K | Buy |
+50,048
| New | +$357K | ﹤0.01% | 1437 |
|
|
2020
Q1 | – | Sell |
-29,346
| Closed | -$168K | – | 1200 |
|
|
2019
Q4 | $168K | Buy |
+29,346
| New | +$157K | ﹤0.01% | 1368 |
|
Other funds holding DVAX
ExodusPoint Capital Management's DVAX Position: Q1 2026 in Review
ExodusPoint Capital Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 104,602 shares — an estimated $1.61M sold.
ExodusPoint Capital Management first reported a position in DVAX in Q4 2019 and held it in 13 quarters. The position peaked at $2.14M in Q3 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- ExodusPoint Capital Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- ExodusPoint Capital Management sold 104,602 Dynavax Technologies shares in Q1 2026, an estimated $1.61M.
- ExodusPoint Capital Management first reported a position in Dynavax Technologies in Q4 2019 and held it in 13 quarters.
- ExodusPoint Capital Management's Dynavax Technologies position peaked at $2.14M in Q3 2025.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.